NorstellaLinQ: Addressing Cost Barriers and Enhancing Medicare Access Strategies to Improve Commercialization Strategy
MMIT’s NorstellaLinQ transforms complex real-world data (RWD) into actionable insights that help pharma manufacturers refine Medicare access strategies, address affordability barriers, and support commercialization in rare disease markets. By identifying patients earlier in their treatment journey, NorstellaLinQ empowers companies to drive both business growth and patient equity.
Download the Use Case
Refine Market Access
Address affordability challenges that limit uptake of rare disease therapies.
Identify Unmet Needs
Leverage RWD to uncover gaps in the treatment landscape for recurrent infections and rare conditions.
Improve Commercialization Strategy
Translate real-world insights into scalable strategies that balance growth and patient access.